Acdal, Melissa C.
HRN: 23-14-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/04/2023
06/11/2023
IV
2.25gm
Q8
S/p Appendectomy
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes